drugset / Trial / NCT00152945

Determining the Responsiveness of Intestinal Lipoprotein Production to an Elevation of Plasma Free Fatty Acids

NCT00152945

Completed 10 enrolled University Health Network, Toronto
RandomizedSingle-groupOpen-labelDiagnostic

Summary

Lipoproteins are large complexes of molecules that transport lipids (primarily triglycerides and cholesterol) through the blood. The intestine has traditionally been viewed as a 'passive' organ with respect to lipoprotein production, with intestinal lipoprotein production rates responding mainly to fat ingestion and absorption. The investigators have recently demonstrated in animal models that there is an overproduction of intestinal lipoproteins in both the fasted and the fed state. The investigators have also recently demonstrated that an elevation of plasma free fatty acids (FFAs) stimulates intestinal lipoprotein in hamsters. It is not known whether intestinal lipoprotein production can be acutely stimulated by an elevation of plasma FFAs in humans. Hypothesis: Intestinal lipoprotein particle production in humans can be stimulated by an acute elevation of plasma free fatty acids.

Timeline

Start
2005-04
Primary completion
2008-07
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Intralipid Other / unclassified 40 ml Intravenous
Background Glycerol Small molecule 100 unknown Intravenous
Background Glycerol Small molecule 2.25 g Intravenous
Background amino acids Unknown 0.6 mg/kg Intravenous

Indications

No indication recorded.